Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: BAY W 6228; Baycol; Certa; Cervasta; Cholstat; Lipobay; Liposterol; Micro®; Rivastatin; Selta; Staltor; Stativa™; Vaslip; Zenas Micro

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer
  • Developer Bayer; Chiesi; Ferrer; Fournier Pharma; Fournier Pharma Inc; GlaxoSmithKline; Laboratorios Vita
  • Class Antihyperlipidaemics; Pyridines
  • Mechanism of Action HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia; Low HDL cholesterol

Most Recent Events

  • 24 Apr 2003 Groupe Fournier is now called Fournier Pharma
  • 23 Aug 2001 Withdrawn for Hypercholesterolaemia in Japan (PO)
  • 09 Aug 2001 Bayer has withdrawn cerivastatin worldwide except in Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top